Xencor, Inc. (XNCR)
28.26
-0.18
(-0.63%)
USD |
NASDAQ |
Aug 27, 12:04
Xencor Market Cap : 2.101B for Aug. 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 26, 2026 | 2.114B |
| August 25, 2026 | 2.178B |
| August 24, 2026 | 2.155B |
| August 21, 2026 | 2.066B |
| August 20, 2026 | 2.007B |
| August 19, 2026 | 2.046B |
| August 18, 2026 | 1.889B |
| August 17, 2026 | 1.718B |
| August 14, 2026 | 1.735B |
| August 13, 2026 | 1.709B |
| August 12, 2026 | 1.723B |
| August 11, 2026 | 1.643B |
| August 10, 2026 | 1.604B |
| August 07, 2026 | 1.547B |
| August 06, 2026 | 1.487B |
| August 05, 2026 | 1.475B |
| August 04, 2026 | 1.481B |
| August 03, 2026 | 1.442B |
| July 31, 2026 | 1.497B |
| July 30, 2026 | 1.592B |
| July 29, 2026 | 1.446B |
| July 28, 2026 | 1.479B |
| July 27, 2026 | 1.471B |
| July 24, 2026 | 1.440B |
| July 23, 2026 | 1.446B |
| Date | Value |
|---|---|
| July 22, 2026 | 1.445B |
| July 21, 2026 | 1.515B |
| July 20, 2026 | 1.393B |
| July 17, 2026 | 1.294B |
| July 16, 2026 | 1.107B |
| July 15, 2026 | 1.109B |
| July 14, 2026 | 1.107B |
| July 13, 2026 | 1.108B |
| July 10, 2026 | 1.174B |
| July 09, 2026 | 1.194B |
| July 08, 2026 | 1.219B |
| July 07, 2026 | 1.161B |
| July 06, 2026 | 1.103B |
| July 02, 2026 | 1.111B |
| July 01, 2026 | 1.139B |
| June 30, 2026 | 1.192B |
| June 29, 2026 | 1.155B |
| June 26, 2026 | 1.115B |
| June 25, 2026 | 1.092B |
| June 24, 2026 | 1.070B |
| June 23, 2026 | 1.043B |
| June 22, 2026 | 1.038B |
| June 18, 2026 | 936.17M |
| June 17, 2026 | 946.54M |
| June 16, 2026 | 903.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Incyte Corp. | 25.66B |
| Regeneron Pharmaceuticals, Inc. | 84.13B |
| MacroGenics, Inc. | 260.31M |
| ACADIA Pharmaceuticals, Inc. | 5.097B |
| Alnylam Pharmaceuticals, Inc. | 31.19B |
Market Cap Related Metrics
| PS Ratio | 20.20 |
| Price to Book Value | 4.174 |
| Price | 28.26 |
| Earnings Yield | -7.68% |